The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property & Equity Holdings Pvt Ltd & PACs

Promoter bought stakeOwnership Changes View source PDF Explain this filing

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.5%Reaction day

₹136.00

prior close

₹140.99

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+2.4%+4.2% vs market

Healthcare Services peers, median of 57sector · industry level+0.5%+6.0% vs sector

On the reaction day the stock moved 4.2 pts more than Nifty Microcap 250 and 6.0 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.0

10m

-2.0

15m

-2.1

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.5+2.4+4.2+0.5+6.0

Next day

+3.8+2.3+1.6+0.9+2.9

+1.2+2.0-0.8-0.5+1.7

+1.4-1.0+2.4-2.1+3.5

+0.2-1.6+1.8-3.7+3.9

+0.8-0.6+1.4-3.3+4.0

-1.1-0.8-0.3-3.5+2.4

15d

+16.2-0.1+16.3-5.0+21.2

+44.9+7.7+37.2+2.0+42.8

+59.6+18.8+40.8+12.0+47.6

+98.5+18.1+80.4+11.7+86.8

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 57Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The promoter group of Suven Life Sciences, led by Jasti Property & Equity Holdings Pvt Ltd (sole trustee of the Jasti Family Trust) along with PACs, has acquired 3,17,68,764 equity shares on 6 March 2026. The shares were allotted on a preferential basis upon conversion of fully paid warrants. As a result, the promoter group's total holding increased from 15,32,31,236 shares (66.06% of equity capital) to 18,50,00,000 shares (70.15% of equity capital), a rise of about 4.17 percentage points. The company's total equity share capital expanded from 23.19 crore to 26.37 crore shares following the allotment. The acquired shares are subject to lock-in as per SEBI ICDR Regulations.

Likely market impact

This is a promoter-led capital infusion that strengthens promoter control to over 70% but does not bring fresh external capital — the shares came from converting existing warrants. Shareholders should note the increased promoter concentration, though the lock-in provides short-to-medium term stability.